SEC 13F Intelligence

Proshare Advisors LLC / ABT

Proshare Advisors LLC’s Abbott Laboratories Position

Does Proshare Advisors LLC own Abbott Laboratories (ABT)? Yes — 1.64M shares worth $168M (+0.25% of its 13F portfolio) as of Q1 2026, up from 1.57M shares the prior filed quarter.

Position Value
$168M
Q1 2026
Shares
1.64M
% of Portfolio
+0.25%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $95MQ4 ’18Q1 ’19: $105MQ2 ’19: $114MQ3 ’19: $112MQ4 ’19: $145MQ4 ’19Q1 ’20: $106MQ2 ’20: $97MQ3 ’20: $128MQ4 ’20: $131MQ4 ’20Q1 ’21: $151MQ2 ’21: $159MQ3 ’21: $174MQ4 ’21: $220MQ4 ’21Q1 ’22: $196MQ2 ’22: $183MQ3 ’22: $166MQ4 ’22: $211MQ4 ’22Q1 ’23: $184MQ2 ’23: $199MQ3 ’23: $180MQ4 ’23: $210MQ4 ’23Q1 ’24: $202MQ2 ’24: $197MQ3 ’24: $215MQ4 ’24: $212MQ4 ’24Q1 ’25: $217MQ2 ’25: $208MQ3 ’25: $220MQ4 ’25: $197MQ4 ’25Q1 ’26: $168Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.64M$168M+0.25%
Q4 20251.57M$197M+0.35%
Q3 20251.64M$220M+0.46%
Q2 20251.53M$208M+0.42%
Q1 20251.64M$217M+0.49%
Q4 20241.88M$212M+0.48%
Q3 20241.89M$215M+0.53%
Q2 20241.90M$197M+0.53%
Q1 20241.77M$202M+0.54%
Q4 20231.91M$210M+0.64%
Q3 20231.85M$180M+0.56%
Q2 20231.83M$199M+0.58%
Q1 20231.81M$184M+0.56%
Q4 20221.92M$211M+0.74%
Q3 20221.72M$166M+0.64%
Q2 20221.68M$183M+0.61%
Q1 20221.65M$196M+0.42%
Q4 20211.57M$220M+0.43%
Q3 20211.47M$174M+0.49%
Q2 20211.38M$159M+0.47%
Q1 20211.26M$151M+0.47%
Q4 20201.20M$131M+0.49%
Q3 20201.17M$128M+0.59%
Q2 20201.06M$97M+0.52%
Q1 20201.34M$106M+0.76%
Q4 20191.66M$145M+0.67%
Q3 20191.33M$112M+0.63%
Q2 20191.35M$114M+0.68%
Q1 20191.31M$105M+0.63%
Q4 20181.32M$95M+0.67%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Proshare Advisors LLC’s full portfolio or all institutional holders of ABT.